S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
Coinbase Stock is Giving an Opening for Buyers
On Holding AG Stock Could be a New Trend on Many Levels
Saia Upgraded Ahead Of Earnings
Dow drops 1,000 points as markets extend slide in 2022
Kohl's confirms approach about potential acquisition
Fed to signal rate hike as it launches risky inflation fight
World shares mostly lower ahead of Federal Reserve meeting
S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
Coinbase Stock is Giving an Opening for Buyers
On Holding AG Stock Could be a New Trend on Many Levels
Saia Upgraded Ahead Of Earnings
Dow drops 1,000 points as markets extend slide in 2022
Kohl's confirms approach about potential acquisition
Fed to signal rate hike as it launches risky inflation fight
World shares mostly lower ahead of Federal Reserve meeting
S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
Coinbase Stock is Giving an Opening for Buyers
On Holding AG Stock Could be a New Trend on Many Levels
Saia Upgraded Ahead Of Earnings
Dow drops 1,000 points as markets extend slide in 2022
Kohl's confirms approach about potential acquisition
Fed to signal rate hike as it launches risky inflation fight
World shares mostly lower ahead of Federal Reserve meeting
S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
Coinbase Stock is Giving an Opening for Buyers
On Holding AG Stock Could be a New Trend on Many Levels
Saia Upgraded Ahead Of Earnings
Dow drops 1,000 points as markets extend slide in 2022
Kohl's confirms approach about potential acquisition
Fed to signal rate hike as it launches risky inflation fight
World shares mostly lower ahead of Federal Reserve meeting
NASDAQ:ROIV

Roivant Sciences Stock Forecast, Price & News

$7.28
+0.03 (+0.41%)
(As of 01/24/2022 12:00 AM ET)
Add
Compare
Today's Range
$6.76
▼
$7.30
50-Day Range
$6.92
▼
$12.46
52-Week Range
$5.80
▼
$16.76
Volume
369,300 shs
Average Volume
334,753 shs
Market Capitalization
$4.99 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
View Price History Chart DataSkip Price History Chart
30 days | 90 days | 365 days | Advanced Chart
Receive ROIV News and Ratings via Email

Sign-up to receive the latest news and ratings for Roivant Sciences and its competitors with MarketBeat's FREE daily newsletter.


Roivant Sciences logo

About Roivant Sciences

Roivant Sciences is a biopharmaceutical company dedicated to improving the delivery of healthcare to patients. Roivant Sciences, formerly known as Montes Archimedes Acquisition Corp., is based in NEW YORK.

Headlines

Roivant Sciences (NASDAQ:ROIV) Stock Price Down 12.7%
January 21, 2022 |  americanbankingnews.com
Roivant Sciences (NASDAQ:ROIV) Stock Price Down 10.2%
January 18, 2022 |  americanbankingnews.com
Roivant Sciences Ltd (NASDAQ:ROIV) Given Consensus Recommendation of "Buy" by Brokerages
January 15, 2022 |  americanbankingnews.com
Roivant Sciences (NASDAQ:ROIV) Stock Price Down 8.3%
January 10, 2022 |  americanbankingnews.com
Premarket Movers: Zynga, Assurant, Roivant Sciences
January 10, 2022 |  barrons.com
Roivant Sciences Reports Licensing Of Splicing Modulator
January 7, 2022 |  benzinga.com
Roivant Sciences licenses transfusion-dependent anemia treatment from Eisai
January 5, 2022 |  seekingalpha.com
Roivant Licenses Splicing Modulator and Announces Upcoming Presentation at 40th Annual J.P. Morgan Healthcare Conference
January 5, 2022 |  finance.yahoo.com
Here's Why Axovant Sciences Stock Skyrocketed Today
January 3, 2022 |  finance.yahoo.com
Roivant Sciences Shares Halted On Circuit Breaker To Upside; Up 25%
December 23, 2021 |  benzinga.com
Roivant Sciences Shares Resume Trading, Continue Higher; Up 40%
December 20, 2021 |  benzinga.com
Roivant Sciences Up 28%, Continuing Increase
December 20, 2021 |  marketwatch.com
Roivant Sciences Uptick Continues
December 20, 2021 |  nasdaq.com
See More Headlines

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
N/A
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ROIV
Previous Symbol
CUSIP
N/A
CIK
1635088
Web
roivant.com
Phone
N/A
Fax
N/A
Employees
2,021
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Price-To-Earnings

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A

Miscellaneous

Outstanding Shares
684,789,000
Free Float
N/A
Market Cap
$4.99 billion
Optionable
Not Optionable

Company Calendar

Last Earnings
11/15/2021
Today
1/25/2022
Fiscal Year End
3/31/2022

MarketRank™

Overall MarketRank™

1.70 out of 5 stars

Medical Sector

732nd out of 1,415 stocks

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Roivant Sciences (NASDAQ:ROIV) Frequently Asked Questions

Is Roivant Sciences a buy right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Roivant Sciences in the last year. There are currently 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Roivant Sciences stock.
View analyst ratings for Roivant Sciences or view top-rated stocks.

How were Roivant Sciences' earnings last quarter?

Roivant Sciences Ltd (NASDAQ:ROIV) announced its earnings results on Monday, November, 15th. The company reported ($0.87) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($1.06) by $0.19. The business earned $13.99 million during the quarter, compared to analysts' expectations of $5.30 million.
View Roivant Sciences' earnings history.

What price target have analysts set for ROIV?

7 Wall Street analysts have issued 12-month price objectives for Roivant Sciences' shares. Their forecasts range from $10.00 to $15.00. On average, they expect Roivant Sciences' share price to reach $12.67 in the next twelve months. This suggests a possible upside of 74.0% from the stock's current price.
View analysts' price targets for Roivant Sciences or view top-rated stocks among Wall Street analysts.

What is Roivant Sciences' stock symbol?

Roivant Sciences trades on the NASDAQ under the ticker symbol "ROIV."

How do I buy shares of Roivant Sciences?

Shares of ROIV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Roivant Sciences' stock price today?

One share of ROIV stock can currently be purchased for approximately $7.28.

How much money does Roivant Sciences make?

Roivant Sciences has a market capitalization of $4.99 billion.

How many employees does Roivant Sciences have?

Roivant Sciences employs 2,021 workers across the globe.

What is Roivant Sciences' official website?

The official website for Roivant Sciences is roivant.com.

Where are Roivant Sciences' headquarters?

Roivant Sciences is headquartered at Clarendon House, 2 Church Street, Hamilton Parish HM 11.


This page was last updated on 1/25/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.